MADRIGAL PHARMACEUTICALS, INC.
MDGL · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Sibold William John: Form 4
Insider disclosure · Filed · Report period 09 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- MDGL · 558868105 - Common Stock
Company details and SEC sources
CIK 0001157601 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MDGL on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1001 Conshohocken State Road, Suite 2 350, West Conshohocken, PA
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- SYNTA PHARMACEUTICALS CORP (to 01 Aug 2016)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields